Faslodex Registry: fulvestrant in current clinical practice

Study identifier:NIS-OBE-FAS-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Faslodex Registry: a Belgian observational study to evaluate the use of fulvestrant in current clinical practice

Medical condition

Metastatic Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual enrollment

200

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Oct 2008
Primary Completion Date: -
Study Completion Date: 01 Dec 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria